UniProt ID | MGLL_HUMAN | |
---|---|---|
UniProt AC | Q99685 | |
Protein Name | Monoglyceride lipase {ECO:0000312|HGNC:HGNC:17038} | |
Gene Name | MGLL {ECO:0000312|HGNC:HGNC:17038} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 303 | |
Subcellular Localization |
Cytoplasm, cytosol . Membrane Peripheral membrane protein . |
|
Protein Description | Converts monoacylglycerides to free fatty acids and glycerol. Hydrolyzes the endocannabinoid 2-arachidonoylglycerol, and thereby contributes to the regulation of endocannabinoid signaling, nociperception and perception of pain (By similarity). Regulates the levels of fatty acids that serve as signaling molecules and promote cancer cell migration, invasion and tumor growth. [PubMed: 20079333] | |
Protein Sequence | MPEESSPRRTPQSIPYQDLPHLVNADGQYLFCRYWKPTGTPKALIFVSHGAGEHSGRYEELARMLMGLDLLVFAHDHVGHGQSEGERMVVSDFHVFVRDVLQHVDSMQKDYPGLPVFLLGHSMGGAIAILTAAERPGHFAGMVLISPLVLANPESATTFKVLAAKVLNLVLPNLSLGPIDSSVLSRNKTEVDIYNSDPLICRAGLKVCFGIQLLNAVSRVERALPKLTVPFLLLQGSADRLCDSKGAYLLMELAKSQDKTLKIYEGAYHVLHKELPEVTNSVFHEINMWVSQRTATAGTASPP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
6 | Phosphorylation | --MPEESSPRRTPQS --CCCCCCCCCCCCC | 26.21 | 21815630 | |
9 (in isoform 2) | Phosphorylation | - | 54.89 | 26852163 | |
10 | Phosphorylation | EESSPRRTPQSIPYQ CCCCCCCCCCCCCHH | 27.27 | 26657352 | |
10 (in isoform 2) | Phosphorylation | - | 27.27 | 26852163 | |
15 (in isoform 2) | Phosphorylation | - | 26.44 | 22199227 | |
16 (in isoform 2) | Phosphorylation | - | 17.00 | 22199227 | |
20 | Phosphorylation | SIPYQDLPHLVNADG CCCHHHCCCCCCCCC | 27.36 | 27251275 | |
36 | Ubiquitination | YLFCRYWKPTGTPKA EEEEEEECCCCCCCE | 24.62 | - | |
58 | Nitrated tyrosine | AGEHSGRYEELARML CCCCCCHHHHHHHHH | 19.79 | - | |
58 | Nitration | AGEHSGRYEELARML CCCCCCHHHHHHHHH | 19.79 | - | |
188 | Ubiquitination | SSVLSRNKTEVDIYN HHHHCCCCCEEEEEC | 44.97 | - | |
189 | Phosphorylation | SVLSRNKTEVDIYNS HHHCCCCCEEEEECC | 44.80 | 23312004 | |
196 | Phosphorylation | TEVDIYNSDPLICRA CEEEEECCCCCHHHH | 24.51 | 23312004 | |
206 | Phosphorylation | LICRAGLKVCFGIQL CHHHHCHHHHHHHHH | 35.72 | 27251275 | |
248 | Phosphorylation | LCDSKGAYLLMELAK HCCCHHHHHHHHHHH | 14.72 | - | |
256 | Phosphorylation | LLMELAKSQDKTLKI HHHHHHHCCCCEEEH | 37.70 | 24719451 | |
260 | Phosphorylation | LAKSQDKTLKIYEGA HHHCCCCEEEHHHHH | 41.39 | 28258704 | |
266 | Phosphorylation | KTLKIYEGAYHVLHK CEEEHHHHHHHHHHH | 17.92 | 24719451 | |
299 | Phosphorylation | QRTATAGTASPP--- HCCCCCCCCCCC--- | 22.84 | 23403867 | |
301 | Phosphorylation | TATAGTASPP----- CCCCCCCCCC----- | 37.23 | 20886841 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of MGLL_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of MGLL_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MGLL_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SCG1_HUMAN | CHGB | physical | 16169070 | |
HPCL1_HUMAN | HPCAL1 | physical | 26186194 | |
MGLL_HUMAN | MGLL | physical | 19957260 | |
HPCL1_HUMAN | HPCAL1 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...